Status:
COMPLETED
Improving Glycemic Control on GMS: A Quality Improvement Study
Lead Sponsor:
Brigham and Women's Hospital
Collaborating Sponsors:
Novo Nordisk A/S
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will examine whether new processes and technologies for monitoring diabetic patients' insulin levels improves patient care at Brigham and Women's Hospital.
Detailed Description
This study will examine whether new processed and technologies for monitoring diabetic patients' insulin levels improves patient care. Patients at Brigham and Women's Hospital (BWH), staying on the Ge...
Eligibility Criteria
Inclusion
- Subjects will include all type 2 diabetic patients on the General Medicine Service (GMS) of Brigham and Women's Hospital (BWH) who do not have an indication for IV insulin.
Exclusion
- Type 2 diabetic patients on the General Medicine Service (GMS) of Brigham and Women's Hospital (BWH) who have an indication for IV insulin.
Key Trial Info
Start Date :
May 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2011
Estimated Enrollment :
179 Patients enrolled
Trial Details
Trial ID
NCT00271700
Start Date
May 1 2010
End Date
March 1 2011
Last Update
August 13 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02120